Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Life and death decisions by E2F-1.

L A Bell1, K M Ryan

  • 1Tumour Cell Death Laboratory, Beatson Institute for Cancer Research, Cancer Research UK Beatson Laboratories, Garscube Estate, Switchback Road, Glasgow G61 1BD, UK. k.ryan@beatson.gla.ac.uk

Cell Death and Differentiation
|October 4, 2003
PubMed
Summary

The transcription factor E2F-1 plays a dual role in cancer, promoting cell growth and cell death. Recent research clarifies E2F-1

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MOF-74(M) (M = Mg(II), Fe(II), Ni(II)) frameworks to enable accelerated redox kinetics for Li-S batteries.

Scientific reports·2025
Same author

Blocking Deoxycytidine Kinase in Activated Lymphocytes Depletes Deoxycytidine Triphosphate Pools and Alters Cell Cycle Kinetics to Yield Less Disease in a Mouse Multiple Sclerosis Model.

Immunology·2024
Same author

From Molecules to Mind: Mechanisms of Action of Electroconvulsive Therapy.

Focus (American Psychiatric Publishing)·2020
Same author

From molecules to mind: mechanisms of action of electroconvulsive therapy.

Acta psychiatrica Scandinavica·2018
Same author

Low temperature solution synthesis of silicon, germanium and Si-Ge axial heterostructures in nanorod and nanowire form.

Chemical communications (Cambridge, England)·2018
Same author

Loss of RhoA promotes skin tumor formation and invasion by upregulation of RhoB.

Oncogene·2017

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • E2F-1, a key transcription factor, is frequently deregulated in human cancers.
  • E2F-1 exhibits paradoxical roles, potentially promoting tumor growth or suppressing it via cell death.
  • While E2F-1's role in cell cycle progression is understood, its mechanisms in inducing apoptosis are complex and less defined.

Purpose of the Study:

  • To review recent findings on E2F-1's role in programmed cell death (apoptosis).
  • To elucidate the complex pathways of E2F-1-induced apoptosis.
  • To discuss the implications of E2F-1's function in cancer and its potential for targeted therapies.

Main Methods:

  • Review of recent scientific literature focusing on E2F-1 and apoptosis.
  • Analysis of findings from E2F-1 knockout mouse models.
  • Synthesis of current understanding regarding E2F-1's molecular mechanisms in cell death.

Main Results:

  • E2F-1 knockout mice exhibit a high propensity for tumor development, underscoring its tumor-suppressive role.
  • Recent studies have significantly advanced the understanding of E2F-1's involvement in apoptosis.
  • The pathways linking E2F-1 to cell death are intricate and multifaceted.

Conclusions:

  • E2F-1 is a critical regulator with complex roles in cancer, capable of both promoting and suppressing tumor development.
  • Further research into E2F-1-mediated apoptosis pathways is crucial for understanding its overall impact on cancer.
  • E2F-1 represents a promising target for novel cancer therapies.

Related Experiment Videos